Clinical Epidemiology of Dengue and COVID-19 Co-infection Among the Residents in Dhaka, Bangladesh, 2021–2023: A Cross-sectional Study - Summary - MDSpire

Clinical Epidemiology of Dengue and COVID-19 Co-infection Among the Residents in Dhaka, Bangladesh, 2021–2023: A Cross-sectional Study

  • By

  • Nadim Sharif

  • Rubayet Rayhan Opu

  • Afsana Khan

  • Tama Saha

  • Abdullah Ibna Masud

  • Jannatin Naim

  • Zaily Leticia Velázquez Martinez

  • Carlos Osorio García

  • Meshari A Alsuwat

  • Fuad M Alzahrani

  • Khalid J Alzahrani

  • Isabel De la Torre Díez

  • Shuvra Kanti Dey

  • January 25, 2025

  • 0 min

Share

Objective:

To determine the epidemiology, co-prevalence, associated factors, and health risks of dengue and COVID-19 co-infection among residents in Dhaka, Bangladesh, highlighting the significance of addressing the knowledge gap.

Key Findings:
  • 31% of participants had co-infection of dengue and COVID-19.
  • Higher co-prevalence observed in Jatrabari (14%) and Motijhil (11%).
  • Severe symptoms were prevalent among participants aged >50 years (65% severe, 78% very severe).
  • Co-infected participants had a higher frequency of heart damage (31.6%), brain fog (22%), and kidney damage (49.3%).
  • Fever (100%) was the most prevalent symptom, followed by weakness (89.6%) and chills (82.4%).
  • Area of residence, number of family members, and population density were associated with higher odds of co-infection.
  • Long-term illness was prevalent among co-infected participants (35%).
Interpretation:

Co-infection of dengue and COVID-19 poses significant health risks, particularly among older adults and in densely populated areas, necessitating urgent public health responses.

Limitations:
  • Convenience sampling may introduce bias, potentially affecting the generalizability of the findings.
  • Study limited to local residents and may not represent the broader population.
Conclusion:

This study highlights the urgent need for enhanced surveillance and public health strategies to address the co-infection of dengue and COVID-19 in Bangladesh, emphasizing the health risks identified.

Original Source(s)

Clinical Epidemiology of Dengue and COVID-19 Co-infection Among the Residents in Dhaka, Bangladesh, 2021–2023: A Cross-sectional Study

  • by Nadim Sharif, Rubayet Rayhan Opu, Afsana Khan, Tama Saha, Abdullah Ibna Masud, Jannatin Naim, Zaily Leticia Velázquez Martinez, Carlos Osorio García, Meshari A Alsuwat, Fuad M Alzahrani, Khalid J Alzahrani, Isabel De la Torre Díez, Shuvra Kanti Dey

  • January 25, 2025

Related Content

Hantavirus Outbreak Revives COVID-Era False Health Claims — The Monitor

Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study